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Abstract
Background: Growth and maintenance of hydatid cysts produced by Echinococcus granulosus have a high requirement for
host lipids for biosynthetic processes, membrane building and possibly cellular and developmental signalling. This requires
a high degree of lipid trafficking facilitated by lipid transporter proteins. Members of the fatty acid binding protein (FABP)
family have been identified in Echinococcus granulosus, one of which, EgFABP1 is expressed at the tegumental level in the
protoscoleces, but it has also been described in both hydatid cyst fluid and secretions of protoscoleces. In spite of a
considerable amount of structural and biophysical information on the FABPs in general, their specific functions remain
mysterious.
Methodology/Principal Findings: We have investigated the way in which EgFABP1 may interact with membranes using a
variety of fluorescence-based techniques and artificial small unilamellar vesicles. We first found that bacterial recombinant
EgFABP1 is loaded with fatty acids from the synthesising bacteria, and that fatty acid binding increases its resistance to
proteinases, possibly due to subtle conformational changes induced on EgFABP1. By manipulating the composition of lipid
vesicles and the ionic environment, we found that EgFABP1 interacts with membranes in a direct contact, collisional,
manner to exchange ligand, involving both ionic and hydrophobic interactions. Moreover, we observed that the protein can
compete with cytochrome c for association with the surface of small unilamellar vesicles (SUVs).
Conclusions/Significance: This work constitutes a first approach to the understanding of protein-membrane interactions of
EgFABP1. The results suggest that this protein may be actively involved in the exchange and transport of fatty acids
between different membranes and cellular compartments within the parasite.
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Introduction
Hydatidosis is a highly pathogenic infection with an almost
global incidence caused by the larval stage (metacestode) of the
cestode Echinococcus granulosus. In endemic areas it has serious
health effects on humans, livestock and wildlife, representing a
major public health and economic burden in many countries [1–
3]. Echinococcus species, as do other tapeworms of mammals,
require two hosts to complete their life cycle. The E. granulosus eggs
containing the infective oncosphere are shed in the faeces of wild
and domestic carnivores that are the definitive hosts harbouring
the dwarf adult tapeworms. Once a suitable intermediate host
ingests the eggs, they hatch and the oncosphere is released,
escaping from the intestine to establish hydatid cysts in liver and
lungs. The cyst produces thousand of protoscoleces, each of which
can progress to the adult form when ingested by the definitive host
[4], but it is the hydatid cysts in intermediate hosts that cause
significant pathology and death. Hydatid disease in humans is
highly pathogenic and is particularly difficult to treat successfully,
especially so when cysts develop and proliferate in the lungs.
Fatty acid binding proteins (FABPs) are small proteins (14–
15 kDa) that bind non-covalently to hydrophobic ligands, mainly
fatty acids (FA) and retinoids. FABPs are confined to the interior of
the synthesising cells, the only known exceptions to this being in
nematodes [5,6]. Several tissue-specific FABP types have been
identified in vertebrates, each named after the tissue in which they
are predominantly expressed, and have also been given numeric
designations [7]. In mammals they are implicated in intracellular
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uptake, storage and transport of FAs in lipid metabolism and
membrane building, as well as protection from the membrane-
disruptive effects of free long chain FAs [8]. In addition, the non-
FA-binding retinoid-binding isoforms contribute to regulation of
gene expression [9]. However, the precise function of each FABP
type remains poorly understood, but sub-specialization of func-
tions is suggested by the tissue-specific and temporal expression, in
addition to ligand preferences [10]. Despite very similar tertiary
structures, FABPs have been found to interact with membranes in
different ways that might reflect how they acquire and deliver their
cargoes. The fluorescence-based biophysical approaches used for
this have shown that most FABPs from mammals (adipocyte
FABP, intestinal FABP, heart FABP, keratinocyte FABP, myelin
FABP, etc.) and one from Schistosomes (Sj-FABPc) exhibit a
collisional mechanism of ligand exchange, meaning that they
interact by direct contact with a membrane in ligand transfer. In
contrast, only liver FABP and cellular retinol binding protein II
from mammals transfer ligands in a diffusional mechanism,
meaning that transfer occurs without requiring direct contact
between protein and membrane but through release of ligand into
the aqueous phase followed by its intercalation into the
membrane. Proteins like liver FABP may therefore be more
involved in lipid storage and regulation in the cytoplasm rather
than in direct transport of FAs [8,11,12].
FABPs of parasitic platyhelminths are interesting because these
parasites are unable to synthesise most of their own lipids de novo, in
particular long-chain FAs and cholesterol [13,14]. Such lipids
must therefore be acquired from the host, and then delivered by
carrier proteins to specific destinations within the parasite.
Whether they are involved extracellularly in lipid acquisition
from, or delivery to, host cells, remains to be seen. It is noteworthy
that EgFABP1 has been found in hydatid cyst fluid and in
protoscolex secretions [15,16]. A final reason for interest in FABPs
is their potential role in drug delivery and the fact that they have
been assayed as vaccine candidates [17–23].
EgFABP1 is considered to be a member of the heart FABP
subfamily [24,25], whose members are believed to be involved in
lipid oxidation processes [8]. The ligand-binding properties of
EgFABP1 have been investigated by the displacement of cis-
parinaric acid by a set of hydrophobic ligands [26], and its crystal
structure reveals the 10-stranded b-barrel fold typical of the family
of intracellular lipid-binding proteins [27].
The objective of this study was to investigate the lipid transport
properties and protein-membrane interaction characteristics of
EgFABP1. We characterise the biophysical properties of the
protein in a number of ways, and show that the protein exchanges
FAs through a collisional, direct contact, mechanism with acceptor
membranes, indicating that it may indeed be involved in FA
dynamics within the parasite, but that it may also engage in direct,
non-specific interactions with host cell membranes.
Materials and Methods
Production of recombinant EgFABP1
The cDNA encoding EgFABP1 (UniProtKB/Swiss-Prot Q02970)
was subcloned into pET11b. The expression of the protein was
carried out in E. coli BL21(DE3) by induction with 0.4 mM
isopropyl-beta-D-thiogalactoside for 3 hours at 37uC in Luria
Bertani medium in presence of 100 mg/mL of ampicillin. Cells
were lysed by sonication and the lysate clarified by ultracentrifuga-
tion (25 min, 617006g, 4uC). Following clarification, the superna-
tant was subjected to salting out incubating the protein for 2 hours at
4uC with 0.5 volume of a saturated ammonium sulphate solution.
After centrifugation, the obtained protein solution was applied into a
size exclusion chromatographic column (Sephadex G-50, Pharmacia
Biotech Inc.). The fractions containing EgFABP1 were subsequently
subjected to ionic exchange chromatography employing a MonoQ
column (Pharmacia Biotech Inc.) in order to remove nucleic acids
contamination. Delipidation was carried out using a Lipidex 1000
column (Sigma) at 37uC in a high ionic strength buffer (10 mM
phosphate (K2HPO4 6 mM+KH2PO4 4 mM), 1 M KCl).
Analysis of EgFABP1-bound fatty acids
As an approach for studying binding preferences of EgFABP1,
the lipid moiety of recombinant non-delipidated EgFABP1 was
extracted according to Bligh & Dyer’s method [28] and analysed
on a TLC plate using a mobile phase for resolving neutral lipids
(hexane:diethyl-ether:acetic acid at 80:20:1, v:v:v). The FA
composition of EgFABP1 lipid fraction was analysed by GC of
their methyl esters derivatives methylated with BF3-Methanol
according to the method described by Morrison & Smith [29],
employing an HP 6890 device Hewlett Packard) as described
previously by Mate´ et al. [30].
Limited proteolysis
In order to analyse possible conformational changes between
apo- and holo- forms, EgFABP1 was subjected to limited
proteolysis experiments. The protocol was a modification of that
described by Arighi et al. [31]. Briefly, clostripain (ArgC, Sigma)
was activated by preincubation in 10 mM phosphate (K2HPO4
6 mM+KH2PO4 4 mM), 150 mM KCl, pH 7.4 and 1 mM DTT
for 2 hours. Prior to digestion, delipidated EgFABP1 (0,5 mg/ml)
was incubated for 30 min with either myristic acid, palmitic acid,
stearic acid or oleic acid in ethanol (4:1 mol:mol ligand:protein) to
obtain holo-forms. As a control of the FA solvent used, an equal
volume of ethanol was added to the apo-form. Additional 15 min
incubation with 1 mM DTT was carried out previous to the
addition of the protease. At fixed intervals, samples were collected
and frozen for subsequent analysis by SDS-PAGE. SDS-PAGE
was carried out according to Scha¨gger and von Jagow [32] in
16.5% acrylamide Tris-Tricine. After Coomassie Blue staining
digital images were collected employing an ImageQuant 350
device (GE Healthcare).
Author Summary
Echinococcus granulosus is the causative agent of hydatid-
osis, a zoonotic infection that affects humans and
livestock, representing a public health and economic
burden in many countries. Since the parasites are unable
to synthesise most of their lipids de novo, they must
acquire them from the host and then deliver them by
carrier proteins to specific destinations. E. granulosus
produces in abundance proteins of the fatty acid binding
protein (FABP) family, one of which, EgFABP1 has been
characterised at the structural and ligand binding levels,
but it has not been studied in terms of the mechanism of
its interaction with membranes. We have investigated the
lipid transport properties and protein-membrane interac-
tion characteristics of EgFABP1 by applying biophysical
techniques. We found that EgFABP1 interacts with
membranes by a mechanism which involves direct contact
with them to exchange their cargo. Given that the protein
has been found in the secretions of the parasite, the
implications of its direct interactions with host membranes
should be considered.
Direct Interaction between EgFABP1 and Membranes
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In vitro binding properties of EgFABP1
Fatty acid binding to EgFABP1 was assessed employing a
fluorescent titration assay [33]. Briefly, 0,5 mM anthroyloxy-fatty
acid (AOFA, Molecular Probes) was incubated at 25uC for 3 min
in 40 mM Tris, 100 mM NaCl, pH 7.4 buffer (TBS) with
increasing concentrations of EgFABP1. The AOFAs employed
for binding assays were 12-(9-anthroyloxy)stearic acid (12AS) and
16-(9-anthroyloxy)palmitic acid (16AP). Fluorescence emission at
440 nm was registered after excitation at 383 nm in a Fluorolog-3
Spectrofluorometer (Horiba-Jobin Yvon). An exact equilibrium n-
sites binding model was fitted to fluorescence data (using Microcal
ORIGIN software) as previously described [34].
Vesicle preparation
For AOFA transfer experiments, small unilamellar vesicles (SUVs)
were prepared by sonication and ultracentrifugation as described
previously [35]. The standard vesicles were prepared to contain
90 mol % of egg phosphatidylcholine (EPC) and 10 mol % of N-(7-
nitro-2,1,3-benzoxadiazol-4-yl)-phosphatidylcholine (NBD-PC), which
served as the fluorescent quencher. To increase the negative charge
density of the acceptor vesicles, either 25 mol % of phosphatidylserine
(PS) or cardiolipin (CL) was incorporated into the SUVs in place of an
equimolar amount of EPC. Vesicles were prepared in TBS except for
SUVs containing CL which were prepared in TBS with 1 mM
EDTA. SUVs containing 64 mol % EPC, 10 mol % egg phospha-
tidylethanolamine (EPE), 25 mol % CL and 1 mol % dansyl-phospha-
tidylethanolamine (DPE) were prepared in 20 mM Tris, 0.1 mM
EDTA, pH 7.4 for protein-membrane interaction assays.
Large unilamellar vesicles (LUVs) of EPC were prepared (1 mM
in phospholipids) by extrusion through polycarbonate membranes
of 100 nm pore diameter (Avestin Inc., Ottawa, Canada) as
described previously [35]. All lipids were purchased from Avanti
Polar Lipids.
Relative partition coefficient (KP) determination
Ligand partition between the protein and NBD-containing SUVs
was determined by measuring AOFA fluorescence at different
protein:SUVs ratios obtained by adding SUV to a solution
containing 10 mM EgFABP1 and 1 mM 12AS in buffer TBS at
25uC [36]. The relative partition coefficient (KP) was defined as:
KP~
Ligand{FABP½ 
FABP½  |
SUV½ 
Ligand{SUV½  ð1Þ
Where [Ligand-SUV] and [Ligand-FABP] are the concentration of
AOFA bound to membrane and EgFABP1, respectively, and [FABP]
and [SUV] are the concentration of protein and vesicles. The de-
crease in AOFA fluorescence as a function of SUV is related to KP by
Frel~
a|KP
KPz
SUV½ 
FABP½ 
{b|
SUV½ 
FABP½  ð2Þ
Where Frel, [SUV], [FABP], Kp, a and b are the relative fluorescence,
the molar concentration of SUV, the molar concentration of
EgFABP1, the partition constant and fitting parameters, respectively
[37]. The partition coefficient was used to establish AOFA transfer
assay conditions that ensure essentially unidirectional transfer, as
detailed below.
Transfer of AOFA from EgFABP1 to SUV
A Fo¨rster Resonance Energy Transfer assay was used to
monitor the transfer of 12AS from EgFABP1 to acceptor model
membranes as described in detail elsewhere [11,33,38]. Briefly,
EgFABP1 with bound 12AS was mixed at 25uC with SUVs,
prepared as above, using a stopped-flow RX2000 module (Applied
Photophysics Ltd.) attached to the spectrofluorometer. The NBD
moiety is an energy transfer acceptor of the anthroyloxy group
donor; therefore, the fluorescence of the AOFA is quenched when
the ligand is bound to SUVs that contain NBD-PC. Upon mixing,
transfer of AOFA from protein to membrane is directly monitored
by the time-dependent decrease in anthroyloxy group fluores-
cence. Different SUVs and buffer compositions were employed in
order to analyse the ligand transfer mechanism. Transfer assay
conditions were 15:1 mol:mol EgFABP1:AOFA ratio. SUVs were
added ranging from 1:10 mol:mol to 1:40 mol:mol EgFABP1:-
SUVs. Controls to ensure that photobleaching was eliminated
were performed prior to each experiment, as previously described
[38]. Data were analysed employing SigmaPlot and all curves were
well described by an exponential decay function. For each
experimental condition within a single experiment, at least five
replicates were done.
EgFABP1 interaction with membranes
To analyse the putative association of EgFABP1 with vesicles,
an assay that exploits the well known membrane-interactive
properties of cytochrome c was employed. The binding of
cytochrome c to acidic membranes can be monitored by using a
resonance energy transfer assay [39] in which the dansyl
fluorescence of DPE-labelled SUV is quenched upon binding of
cytochrome c, which contains the heme moiety quencher.
Competition of EgFABP1 with cytochrome c for binding to SUVs
was determined by the relief of cytochrome c-related quenching of
the dansyl fluorescence. In a final volume of 200 ml, 0–48 mM
EgFABP1 was added to 15 mM SUV in 20 mM Tris.HCl/
0.1 mM EDTA, pH 7.4. After a 2 min equilibration, fluorescence
emission at 520 nm was measured (lex = 335 nm). Cytochrome c
(Sigma) was then added (1 mM final concentration), and the
mixture equilibrated an additional 2 min period before monitor-
ing again fluorescence emission at 520 nm. In the absence of
bound FABP, the dose-dependent quenching of dansyl fluores-
cence is observed. An inhibition of cytochrome c-dependent
quenching is interpreted as evidence for EgFABP1 interaction with
SUVs, i.e., EgFABP1 prevention of subsequent cytochrome c
interaction with the bilayer.
Results
Lipid binding by EgFABP1 in a cellular environment
This assay was performed in order to determine which lipid
classes bind to EgFABP1 in a cellular environment. Despite E.
coli’s cytoplasm not being the natural environment of EgFABP1,
this approach could contribute to the assignment of the protein’s
natural ligands as it analyses the preference of EgFABP1 for
different hydrophobic compounds present in the bacterial
cytoplasm. TLC analysis showed that only FAs were bound to
the recombinant protein (data not shown). Among them, palmitic
acid (16:0) and stearic acid (18:0) are important ligands, although
myristic (14:0), pentadecanoic (15:0), palmitoleic (16:1 n-7), 7-
hexadecenoic (16:1 n-9), oleic (18:1 n-9), vaccenic (18:1 n-7), and
linoleic acid (18:2) were also detected (Figure 1). The latter may
come from culture media, as E. coli is not able to synthesise
polyunsaturated FAs, at least during log-phase growth [40,41].
The distribution of FAs bound to FABP may be related to the
relative abundance of each of them in E. coli, and it correlates well
with the reported FA composition of E. coli grown in equivalent
conditions [41]. As in previous in vitro displacement of fluorescent
Direct Interaction between EgFABP1 and Membranes
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ligand studies where palmitic and stearic acids are among those
that produce moderate displacement percentages (.50%) [26],
this experiment shows that EgFABP1 is able to bind many FAs of
different chain length and degree of insaturation. In addition, in
agreement with these results, the crystal structure of recombinant
EgFABP1 revealed an electronic density inside the cavity, which
was interpreted as being palmitic acid [27]. We therefore
proceeded to investigate protein:membrane transfer using fluor-
ophore-tagged fatty acid analogues.
Ligand-induced conformational changes
Partial proteolysis can provide information related to confor-
mational changes in proteins since this technique may reveal the
differential exposure of proteolytic sites in apo and holo forms. We
analysed the peptide pattern obtained by digestion of EgFABP1 in
its apo- or different holo-forms with Clostripain (ArgC). The FAs
selected, following to the analysis of ligands bound to recombinant
EgFABP1 (Figure 1), were myristic, palmitic, stearic and oleic
acids. The enzyme hydrolyses the polypeptide chain at the C-
terminal end of arginine residues. Qualitative differences were
evident between apo-EgFABP1 and the different complexes
(Figure 2). Results show that binding of FAs gives EgFABP1
significant relative protection against cleavage. After 5 minutes of
proteolysis the apo-protein shows several bands corresponding to
proteolytic fragments, while the holo-forms show mainly the band
corresponding to full-length EgFABP1 and less intense bands
corresponding to proteolytic fragments (Figure 2A). This suggests
that ligand-binding results in a different exposure of proteolytic
sites. It is interesting to note that after 16 hours of proteolysis the
holo-proteins do not seem to be further proteolysed while the apo-
protein is almost completely degraded (Figure 2B). Previous
results obtained for other members of the family of FABPs have
suggested that binding of ligands involves conformational changes,
especially on the portal region of FABPs [10,31,42]. Furthermore,
in silico simulations show that, upon ligand binding, subtle
conformational changes can be detected inside the cavity, in the
surface and in the portal region of EgFABP1 (Esteves, unpublished
data). These changes could make cleavage sites less accessible to
the protease.
As an additional approach to investigate conformational changes
between apo- and holo-protein, we analysed the circular dichroism
(CD) spectra of EgFABP1 in the far (200–250 nm) and near (250–
320 nm) UV regions. Two different ligands were employed for the
generation of holo-EgFABP1: palmitic and oleic acid. Results
indicated that the far-UV spectra of apo- and the two holo-forms
did not show appreciable differences as can be seen in Figure S1.
These data could be interpreted to show that no significant changes
in overall secondary structure content are caused by ligand binding.
On the other hand, the near-UV CD spectra (Figure S1) showed
differences upon ligand binding, especially with oleic acid,
indicating a likely alteration in the environment of aromatic
residues resulting from proximity to ligand and/or a change in the
conformation of the protein. So, ligand binding to EgFABP1 could
elicit a change in the tertiary structure of the protein that could be
correlated to the relative resistance of the holo form to proteolytic
attack observed in the previous experiment.
In vitro binding of fluorescent FAs by EgFABP1
In preparation for experiments on the interaction of EgFABP1
with phospholipid vesicles, binding experiments were performed
using fluorescent analogues of stearic and palmitic acids, 12AS and
16AP, respectively. Anthroyloxy probes are useful indicators of
binding site characteristics because their spectral properties are
environment-sensitive. These probes usually have very low
fluorescence intensity in buffer, which becomes dramatically
enhanced upon interaction with a FABP [43]. 12AS showed a
large increase in fluorescence emission accompanied by a
Figure 1. Analysis of FABP-bound FAs. GC analysis of EgFABP1-
bound FAs from E. coli was performed as indicated in Materials and
Methods. Fatty acids detected were: myristic (14:0), pentadecanoic
(15:0), palmitic (16:0), 7-hexadecenoic (16:1 n-9), palmitoleic (16:1 n-7),
stearic (18:0), oleic (18:1 n-9), vaccenic (18:1 n-7), and linoleic acid (18:2).
Average of two different experiments 6 SD are shown.
doi:10.1371/journal.pntd.0001893.g001
Figure 2. Proteolysis of free EgFABP1 and EgFABP1 bound to ligands. Separation by SDS-PAGE of proteolytic fragments of apo-EgFABP1
(lane 1) and samples of this protein preincubated for 30 min with myristic acid (lane 2), palmitic acid (lane 3), stearic acid (lane 4) or oleic acid (lane 5)
to obtain holo-forms, as indicated in Materials and Methods. Lane 6 corresponds to undigested EgFABP1. Samples were taken after 5 min (A) or
16 hours of proteolysis (B). A peptide molecular weight marker is shown in lanes labelled as MWM. This is a representative experiment from two
independent experiments.
doi:10.1371/journal.pntd.0001893.g002
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substantial blue shift upon binding to EgFABP1. On the other
hand, 16AP’s fluorescence was surprisingly decreased when bound
to EgFABP1, but also accompanied by a distinct blue shift in
emission (Figure 3). This blue-shift indicates that the fluorophore
had entered an apolar environment, almost certainly the
hydrophobic binding pocket rather than a superficial, non-specific
site of the protein. Following addition of artificial 100 mol %
phosphatidylcholine LUVs to the 16AP:EgFABP1 complex, the
intensity of fluorescence emission increased, indicating that the
quenching of 16AP’s fluorescence emission was reversed upon
transfer to the different, lipidic, environment of the vesicles. In
both cases (12AS and 16AP) the titration described curves that
reached saturation, in accordance to a ligand binding phenom-
enon consistent with 1:1 binding, with a Kd of 0.1260.02 mM for
12AS, and 0.01360.006 mM for 16AP. 12AS was chosen as a
ligand for the following analysis of transfer kinetics due to its
fluorescence emission characteristics when bound to protein being
more typical of that observed in other studies on protein to
membrane transfer [37,44,45]. However, the quenching effect
observed with 16AP will be very useful to analyse FA transfer
between EgFABP1 and other proteins that show a typical increase
of AOFA fluorescence upon binding. Regarding this, another lipid
binding protein from E. granulosus which is very abundant in the
hydatid fluid, Antigen B, has been investigated in its binding
properties, showing that it binds 16AP with a 30-fold fluorescence
enhancement of the probe [46].
Relative partition coefficient (KP) determination
The apparent partition coefficient that describes the relative
distribution of 12AS between EgFABP1 and EPC-SUVs was
Figure 3. Fluorimetric titration of fluorescent fatty acid analogues with EgFABP1. (A) Emission spectra of 16AP bound to EgFABP1 is
shown. Changes in relative 16AP fluorescence were monitored from 400 to 500 nm after excitation at 383 nm upon incremental 0,05 mM additions of
EgFABP1 to a cuvette initially containing 2 mL of 0,5 mM 16AP in TBS buffer. 16AP emission spectra show a remarkable blue shift that accompanies
fluorescence decrease upon binding to EgFABP1. Fluorescence is recovered after the addition of 10 mM EPC large unilamellar vesicles (LUVs). (B) Emission
spectra of 12AS bound to EgFABP1 are shown. Changes in relative 12AS fluorescence weremonitored from 400 to 500 nm after excitation at 383 nm upon
incremental 0.05 mM additions of EgFABP1 to a cuvette initially containing 2 mL of 0.5 mM 12AS in TBS buffer. 12AS spectra show a remarkable blue shift
that accompanies fluorescence increase. (C) Changes in relative 16AP fluorescence were recorded at 440 nm in order to build the binding isotherm. The
data are consistent with one binding site per monomer unit of protein and a Kd value of 0.01360.006 mM. The solid line is the theoretical binding curve for
complex formation. One representative experiment of three is shown. (D) Changes in relative 12AS fluorescence were recorded at 440 nm to build the
binding isotherm of the complex EgFABP1-12AS. The data are consistent with one binding site per monomer unit of protein and a Kd value of
0.1260.02 mM. The solid line is the theoretical binding curve for complex formation. One representative experiment of four is shown.
doi:10.1371/journal.pntd.0001893.g003
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determined by adding SUVs containing NBD-PC to a solution of
12AS:EgFABP1 complex. As a result of this experiment, a KP
value of 0.4860.23 was obtained employing Eq. 2 (see Materials
and Methods), which indicates that there is preference of the
AOFA for the phospholipid membranes.
Effect of vesicle concentration on AOFA transfer from
EgFABP1 to membranes
In a collisional transfer, the limiting step is the effective protein-
membrane interaction, and the rate increases as the acceptor
membrane concentration increases. In a diffusional mechanism in
which the rate limiting step is the dissociation of the protein-ligand
complex, no change in rate is observed [33,37,38,44,45,47]. The
values of Kd and KP were used to set the conditions for the transfer
assay. The proportion of protein and ligand was such that less than
1% of AOFA remained free in the preincubation solution. On the
other hand, KP value was used to calculate the final concentrations
of protein and SUVs for which unidirectional transfer prevailed.
Figure 4 shows that when constant concentrations of the EgFABP1-
12AS donor complexes were mixed with increasing concentrations
of EPC-SUV, the 12AS transfer rate from EgFABP1 to EPC-SUV
increased proportionally to vesicle concentration in the SUV:
EgFABP1 ratios (10:1 to 40:1) tested. In these conditions, the
increase in transfer rate ranged from 0.0460.01 sec21 to
0.1260.03 sec21. These results strongly suggest that the FA transfer
from EgFABP1 occurs via a protein-membrane interaction rather
than by simple aqueous diffusion of the free ligand.
Effect of phospholipids charge on AOFA transfer from
EgFABP1 to membranes
Considering the hypothesis that FA transfer from EgFABP1
occurs by collisional contact with an acceptor membrane, changes
in membrane properties should modify the transfer rate. If the
mechanism relied on aqueous diffusion alone, then the character-
istics of acceptor membranes should be irrelevant to the transfer
rate, since the rate-determining step in such a transfer process
(ligand dissociation into the aqueous phase) is a physically and
temporally distinct event from processes involving the membrane.
Figure 5 shows that 12AS transfer rate from EgFABP1 to
membranes increased when acceptor membranes contained 25%
of negatively charged phospholipids (PS or CL). In agreement with
the behaviour we have previously observed for collisional
mammalian FABPs [38,44,45,47], EgFABP1 shows a large
increase in FA transfer rate to CL vesicles compared with
zwitterionic vesicles. To investigate further the effect of negative
charge of the acceptor vesicles on the FA transfer mechanism from
the protein, we analysed the modification of transfer rates with
increasing concentrations of negatively charged acceptor vesicles.
The rate of FA transfer from EgFABP1 always, and independently
of the net charge of the vesicles, showed the classical proportional
increase in transfer rate with acceptor concentration (Figure 6).
Effect of ionic strength on AOFA transfer from EgFABP1
to membranes
Transfer of 12AS from EgFABP1 to membranes was examined
as a function of increasing concentrations of NaCl. The results
show that an important increase in transfer rate from EgFABP1 to
neutral membranes was detected with increasing ionic strength of
the aqueous phase (Figure 7A). It is generally thought that
electrostatic interactions at surfaces are diminished and hydro-
phobic interactions are stimulated as a function of increasing ionic
strength. The effect of ionic strength on the rate of AOFA transfer
from EgFABP1 to zwitterionic vesicles suggests that the elimina-
tion of electrostatic interactions by salt shielding is compensated by
an increase in hydrophobic interactions.
When negative charge was added to the acceptor lipid vesicles, a
drastic decrease was observed at high salt concentrations (Figure 7B).
As shown in Figure 5, EgFABP1 exhibited approximately a 60-fold
increase in AOFA transfer rate to CL vesicles compared with EPC
vesicles at low ionic strength. Upon increasing the ionic strength, a
marked decrease from the very high values observed at low ionic
strength was found (Figure 7B). This suggests a masking of
electrostatic interactions, which play a very important role at low
ionic strength, caused by the high salt content of the buffer.
Figure 4. Effect of acceptor membrane concentration on 12AS
transfer from EgFABP1 to EPC/NBD-PC SUVs. SUVs were added
ranging from 1:10 mol:mol to 1:40 mol:mol EgFABP1:SUVs to 15:1
mol:mol EgFABP1:12AS complex. Fatty acid transfer rates were directly
monitored by the time-dependent decrease in anthroyloxy group
fluorescence, as described in Materials and Methods. Average of four
different experiments 6 SD are shown. The inset shows an example of
the kinetic trace obtained when combining EgFABP1-12AS with
membranes that contain NBD-PC.
doi:10.1371/journal.pntd.0001893.g004
Figure 5. Effect of acceptor membrane surface charge on 12AS
transfer rates from EgFABP1 to SUVs. Transfer rate from
EgFABP1:12AS (15:1 mol:mol) complex to 1:20 mol:mol of EPC/NBD-
PC SUVs containing no other phospholipids (zwitterionic vesicles),
25 mol % brain PS (single negative charge) or CL (double negative
charge) were measured. Averages from two different experiments 6 SD
are shown.
doi:10.1371/journal.pntd.0001893.g005
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Direct competitive interaction between EgFABP1 and
cytochrome c with membranes
FA transfer experiments suggest that the interaction of EgFABP1
with membranes is sensitive to surface charge density. As cytochrome
c is known to interact as a peripherally associating protein with acidic
membranes [48], we analysed the ability of EgFABP1 to compete
with cytochrome c for binding to membranes containing CL.
Cytochrome c quenches dansyl fluorescence in a concentration-
dependent manner (ref. [49] and Figure 8). Results show that
preincubation of CL-containing vesicles with EgFABP1 was effective
in preventing cytochrome c binding in a concentration-dependent
manner (Figure 8). When EgFABP1 (48 mM) was added to CL-
containing SUVs, the dansyl fluorescence was twice that obtained in
the absence of EgFABP1 and with 1 mM cytochrome c.
Discussion
We show that recombinant EgFABP1 is able to bind FAs of
different chain lengths from E. coli, mainly palmitic and stearic
acids. This is clearly an incomplete inventory of ligands that it may
transport in the parasite, but it does illustrate the propensity of the
protein to bind FAs when exposed to an environment rich in a
wide range of small hydrophobic compounds. The analysis of the
natural ligands bound by EgFABP1 in the parasite environment is
currently being undertaken in our laboratory.
Our main finding in this work was that the protein engages in a
collisional mechanism in ligand transfer, as do various FABP isoforms
from mammals, and one from Schistosomes, that have been
investigated in this way [8,11,12]. This involvement of direct contact
between protein and membrane for this transfer was found by
altering electrostatic and hydrophobic conditions in the transfer
experiments. The results indicated that the interaction event is
mediated by both charge and hydrophobic factors, and it would seem
reasonable that the initial interaction is ionic, between the protein and
charged phospholipid headgroups, followed by direct, transient
hydrophobic interaction with the apolar layer of the membrane. The
interaction of the protein with membranes has also been demon-
strated by the competition with cytochrome c for membrane binding.
The tertiary structure of EgFABP1 is virtually superimposable
on FABPs that engage in collisional transfers [27], in which the
two alpha-helices adjacent to the portal of ligand entry in FABPs
are important in engaging contact with membranes [38]. It may
be no coincidence that EgFABP1 has, like these other collisional
FABPs, a prominent pair of bulky hydrophobic amino acid
Figure 7. Effect of ionic strength of buffer on 12AS transfer rate
from EgFABP1 to SUVs. Transfer rates from EgFABP1:12AS (15:1
mol:mol) complex to 1:20 mol:mol of EgFABP1:EPC/NBD-PC SUVs (A) or
EPC/NBD-PC SUVs containing 25 mol % CL (B) in presence of increasing
concentrations of NaCl were measured. Average of four different
experiments 6 SD are shown (except data corresponding to 2M NaCl,
which derive from two independent experiments).
doi:10.1371/journal.pntd.0001893.g007
Figure 6. Effect of acceptor membrane concentration on 12AS
transfer rates from EgFABP1 to charged SUVs. Transfer rate from
EgFABP1:12AS (15:1 mol:mol) complex to 1:10 mol:mol or 1:40 mol:mol
EgFABP1:EPC/NBD-PC SUVs containing either (A) 25 mol % PS or (B) CL
were measured. Averages from two different experiments 6 SD are
shown.
doi:10.1371/journal.pntd.0001893.g006
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sidechains (Phe27, Val28) extending into solvent from helix II,
immediately adjacent to the portal. Such a ‘sticky finger’ could
attract and orient ligand for entry into the protein, or be involved
in the protein’s interaction with membranes or other proteins [50].
Our results suggest that EgFABP1 is likely to be an active
participant in the transport and exchange of lipids in vivo, which
could involve uptake of FAs directly from, and delivery to,
membranes within the parasite, potentially resourcing the
developing protoscoleces within the hydatid cysts. This might also
be the case for Antigen B, which belongs to a new family of
hydrophobic ligand binding proteins of cestodes and has been
proposed as a lipoprotein involved in lipid trafficking [46,51].
Furthermore, our proteolysis experiments with EgFABP1 and the
analysis of CD spectra of apo- and holo-forms indicated that
ligand binding would induce a conformational change in the
protein. Such a change might modify the mechanism of
interaction of EgFABP1 with membranes to facilitate upload or
download of their cargo. A conformational change could also
function as a signal to target the protein to different destinations,
as has been suggested for other members of the FABP family
[52,53]. The possibility that it also interacts with host cell
membranes is more contentious, particularly since EgFABP1 does
not have a secretory leader peptide, as is also the case for FABPs
from any group of animals other than nematodes [5,6], so should
be confined to the interior of cells. However, if EgFABP1 appears
in cyst fluid in vivo and in excretion/secretion products of
protoscoleces [15,16] (but not as a result of cell damage during
fluid collection or imperfect culture conditions in the collection of
excretion/secretion products) then the possibility that it does
interact with host cells beyond the cyst wall must be considered.
Host proteins are known to cross hydatid cyst walls [15], so it is
conceivable that this permeability (if a unidirectional transfer
system is not in operation) could mean that EgFABP1 leaves the
cyst to interact with host membranes for return to the parasite, or
to deliver lipids to host tissues for immunomodulation. These
hypotheses remain to be tested. In this regard, future studies
should also include protein interaction analysis with membranes
that mimic parasite and host composition.
This work is a first approach to understand the functional proper-
ties of EgFABP1 and constitutes the basis for further expanding our
knowledge about this protein. This has been the case for other mem-
bers of the FABP family, where this kind of studies has contributed to
the understanding of the mechanisms of ligand transfer to mem-
branes, protein-membrane and protein-protein interactions [8,54].
Supporting Information
Figure S1 Circular dichroism spectra of apo- and holo-
EgFABP1. (A) CD spectra in the FAR UV region of apo-
EgFABP1, palmitic acid-EgFABP1 and oleic acid-EgFABP1.
Results show that ligand binding does not induce significant
changes in the secondary structure of the protein. (B) CD spectra
in the near UV region of the same samples. These results show
that the spectrum of EgFABP1 changes upon ligand binding,
especially when oleic acid is bound to the protein, indicating that
the environment of the aromatic aminoacids is modified.
(TIF)
Protocol S1 Circular dichroism spectra acquisition. Cir-
cular dichroism spectra in the near (250–320 nm) and far (200–
250 nm) UV spectra of EgFABP1 in its apo-form, and bound to
either palmitic or oleic acid.
(DOCX)
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